Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis

Clinical and Experimental Rheumatology

Volumn 26, Issue 5, 2008, Pages 926-928

  Riccio, Antonio ^a   Conca, Paolo ^a   Marzocchella, Carmela ^a   Tarantino, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

HCV; Rheumatoid factor

Indexed keywords

ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; PEGINTERFERON ALPHA2B; RHEUMATOID FACTOR; RIBAVIRIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERTRANSAMINASEMIA; HYPOCOMPLEMENTEMIA; IMMUNE RESPONSE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; RIBAVIRIN; VIRAL LOAD;

EID: 57249111630     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. PAWLOTSKY JM, BEN YAHIA M, ANDRE C et al.: Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 1994; 19: 841-8.
2. KESSEL A, TOUBI E: Chronic HAV-related autoimmunity: a consequence of viral persistence and lymphotropism. Curr Med Chem 2007; 14: 547-54.
3. MCMURRAY RW, ELBOURNE K: Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 26: 689-701.
4. ROZIN AP, LEWIN M, BRAUN-MOSCOVICI Y, ITZHAK OB, BERGMAN R, BALBIR-GURMAN A: Essential mixed cryoglobulinemia type II, Clin Exp Rheumatol 2006; 24: 329-32.
5. LOVY MR, STARKEBAUM G, UBEROI S: Hepatitis C infection presenting with rheumatic manifestations: A mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 979-83.
6. BUSKILA D: Hepatitis C-associated arthritis. Curr Opin Rheumatol 2000; 12: 295-9.
7. LOUSTAUD RATTI V, LUNEL F: Extrahepatic manifestations of hepatitis C virus infection. Rev Prat 2000; 50: 1089-93.
8. CLIFFORD BD, DONAHUE D, SMITH L et al.: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-9.
9. ZIGNEGO AL, MACCHIA D, MONTI M et al.: Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382-6.
10. NASIR A, ARORA HS, KAISER HE: Apoptosis and pathogenesis of viral hepatitis C - an update. In Vivo 2000; 14: 297-300.
11. TOUBI E, KESSEL A, PERt R et al.: Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: Reversal after antiviral treatment. J Virol 2004; 78: 11379-84.
12. TARANTINO G, RICCIO A, SPANÒ A et al.: HCV infection and chronic arthritis: Does viral replication matter? Hepatol Res 2006; 35: 238-41.
13. RAHMAN F, HELLER T, SOBAO Y et al.: Effects of antiviral therapy on the cellular immune response in acute Hepatitis C. Hepatology 2004; 40: 87-97.
14. BARNES E, SALIO M, CERANDOLO V et al.: Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Animicrob Agents Chemother 2004; 48: 3382-9.
15. SLAUGHTER L, CARSON DA, JENSEN FC, HOLBROOK TL, VAUGHAN JH: In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 1978; 148: 1429-34.
16. PILERI P, UEMATSU Y, CAMPAGNOLI S et al.: Binding of hepatitis C virus to CD81. Science 1998; 282: 938-41.
17. MAJDA-STANISLAWSKA E, BEDNAREK M, JOZWIAK B, SIDORKIEWICZ M, PIEKARSKA A, KUYDOWICZ J: Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C. Acta Gastroenterol Belg 2006; 69: 187-90.